Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 13–13 | Cite as

α-1-antitrypsin

Graves' disease: case report
Case report
  • 10 Downloads

Reference

  1. Brener A, et al. Long-term safety of alpha-1 antitrypsin therapy in children and adolescents with type 1 diabetes. Endocrine Reviews 39 (Suppl. 1): No. 2, Apr 2018 [abstract] - IsraelGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations